vs
BALCHEM CORP（BCPC）与CORCEPT THERAPEUTICS INC（CORT）财务数据对比。点击上方公司名可切换其他公司
BALCHEM CORP的季度营收约是CORCEPT THERAPEUTICS INC的1.3倍（$270.7M vs $202.1M），BALCHEM CORP净利率更高（14.9% vs 12.0%，领先2.9%），CORCEPT THERAPEUTICS INC同比增速更快（11.1% vs 8.1%），CORCEPT THERAPEUTICS INC自由现金流更多（$38.4M vs $33.8M），过去两年CORCEPT THERAPEUTICS INC的营收复合增速更高（17.3% vs 7.5%）
Balchem Corp是一家全球特种化学品与营养原料供应商，核心业务覆盖人类营养、动物保健、制药、工业应用四大领域，为北美、欧洲、亚太等地区的客户提供定制化专用原料产品。
Corcept Therapeutics是一家制药企业，专注于严重代谢疾病、精神疾病及肿瘤疾病治疗药物的发现、开发与商业化。公司围绕皮质醇过量带来的不良影响展开研究，致力于开发可缓解相关症状的新型化合物，管理团队由首席执行官兼总裁、董事Joseph K. Belanoff医学博士领导。
BCPC vs CORT — 直观对比
营收规模更大
BCPC
是对方的1.3倍
$202.1M
营收增速更快
CORT
高出3.1%
8.1%
净利率更高
BCPC
高出2.9%
12.0%
自由现金流更多
CORT
多$4.6M
$33.8M
两年增速更快
CORT
近两年复合增速
7.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $270.7M | $202.1M |
| 净利润 | $40.3M | $24.3M |
| 毛利率 | — | 98.7% |
| 营业利润率 | 20.5% | 2.2% |
| 净利率 | 14.9% | 12.0% |
| 营收同比 | 8.1% | 11.1% |
| 净利润同比 | 8.7% | -21.0% |
| 每股收益（稀释后） | $1.25 | $0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCPCCORT
| Q1 26 | $270.7M | — | ||
| Q4 25 | $263.6M | $202.1M | ||
| Q3 25 | $267.6M | $207.6M | ||
| Q2 25 | $255.5M | $194.4M | ||
| Q1 25 | $250.5M | $157.2M | ||
| Q4 24 | $240.0M | $181.9M | ||
| Q3 24 | $239.9M | $182.5M | ||
| Q2 24 | $234.1M | $163.8M |
净利润BCPCCORT
| Q1 26 | $40.3M | — | ||
| Q4 25 | $39.2M | $24.3M | ||
| Q3 25 | $40.3M | $19.7M | ||
| Q2 25 | $38.3M | $35.1M | ||
| Q1 25 | $37.1M | $20.5M | ||
| Q4 24 | $33.6M | $30.7M | ||
| Q3 24 | $33.8M | $47.2M | ||
| Q2 24 | $32.1M | $35.5M |
毛利率BCPCCORT
| Q1 26 | — | — | ||
| Q4 25 | 35.6% | 98.7% | ||
| Q3 25 | 35.7% | 97.8% | ||
| Q2 25 | 36.4% | 98.2% | ||
| Q1 25 | 35.2% | 98.5% | ||
| Q4 24 | 36.0% | 98.4% | ||
| Q3 24 | 35.6% | 98.4% | ||
| Q2 24 | 35.5% | 98.5% |
营业利润率BCPCCORT
| Q1 26 | 20.5% | — | ||
| Q4 25 | 19.8% | 2.2% | ||
| Q3 25 | 20.4% | 4.9% | ||
| Q2 25 | 20.1% | 13.7% | ||
| Q1 25 | 20.4% | 2.2% | ||
| Q4 24 | 19.8% | 13.9% | ||
| Q3 24 | 20.0% | 25.5% | ||
| Q2 24 | 19.6% | 21.7% |
净利率BCPCCORT
| Q1 26 | 14.9% | — | ||
| Q4 25 | 14.9% | 12.0% | ||
| Q3 25 | 15.1% | 9.5% | ||
| Q2 25 | 15.0% | 18.1% | ||
| Q1 25 | 14.8% | 13.1% | ||
| Q4 24 | 14.0% | 16.9% | ||
| Q3 24 | 14.1% | 25.9% | ||
| Q2 24 | 13.7% | 21.7% |
每股收益（稀释后）BCPCCORT
| Q1 26 | $1.25 | — | ||
| Q4 25 | $1.21 | $0.20 | ||
| Q3 25 | $1.24 | $0.16 | ||
| Q2 25 | $1.17 | $0.29 | ||
| Q1 25 | $1.13 | $0.17 | ||
| Q4 24 | $1.03 | $0.25 | ||
| Q3 24 | $1.03 | $0.41 | ||
| Q2 24 | $0.98 | $0.32 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.9M | $372.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.3B | $647.8M |
| 总资产 | $1.7B | $836.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BCPCCORT
| Q1 26 | $72.9M | — | ||
| Q4 25 | $74.6M | $372.2M | ||
| Q3 25 | $65.1M | $421.7M | ||
| Q2 25 | $65.4M | $342.2M | ||
| Q1 25 | $49.9M | $322.8M | ||
| Q4 24 | $49.5M | $383.3M | ||
| Q3 24 | $73.7M | $380.3M | ||
| Q2 24 | $63.7M | $473.2M |
股东权益BCPCCORT
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $647.8M | ||
| Q3 25 | $1.3B | $631.9M | ||
| Q2 25 | $1.3B | $635.8M | ||
| Q1 25 | $1.2B | $683.3M | ||
| Q4 24 | $1.1B | $679.6M | ||
| Q3 24 | $1.2B | $638.8M | ||
| Q2 24 | $1.1B | $596.2M |
总资产BCPCCORT
| Q1 26 | $1.7B | — | ||
| Q4 25 | $1.7B | $836.7M | ||
| Q3 25 | $1.7B | $823.6M | ||
| Q2 25 | $1.7B | $801.7M | ||
| Q1 25 | $1.6B | $846.5M | ||
| Q4 24 | $1.6B | $840.6M | ||
| Q3 24 | $1.6B | $784.3M | ||
| Q2 24 | $1.6B | $714.6M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $40.1M | $38.4M |
| 自由现金流经营现金流 - 资本支出 | $33.8M | $38.4M |
| 自由现金流率自由现金流/营收 | 12.5% | 19.0% |
| 资本支出强度资本支出/营收 | 2.3% | 0.0% |
| 现金转化率经营现金流/净利润 | 0.99× | 1.58× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流BCPCCORT
| Q1 26 | $40.1M | — | ||
| Q4 25 | $67.3M | $38.4M | ||
| Q3 25 | $65.6M | $54.5M | ||
| Q2 25 | $47.3M | $43.9M | ||
| Q1 25 | $36.5M | $5.1M | ||
| Q4 24 | $52.3M | $59.3M | ||
| Q3 24 | $51.3M | $73.8M | ||
| Q2 24 | $45.0M | $41.2M |
自由现金流BCPCCORT
| Q1 26 | $33.8M | — | ||
| Q4 25 | — | $38.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $43.9M | ||
| Q1 25 | — | $5.0M | ||
| Q4 24 | — | $59.2M | ||
| Q3 24 | — | $72.2M | ||
| Q2 24 | — | $40.8M |
自由现金流率BCPCCORT
| Q1 26 | 12.5% | — | ||
| Q4 25 | — | 19.0% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 22.6% | ||
| Q1 25 | — | 3.2% | ||
| Q4 24 | — | 32.5% | ||
| Q3 24 | — | 39.5% | ||
| Q2 24 | — | 24.9% |
资本支出强度BCPCCORT
| Q1 26 | 2.3% | — | ||
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.9% | ||
| Q2 24 | — | 0.3% |
现金转化率BCPCCORT
| Q1 26 | 0.99× | — | ||
| Q4 25 | 1.72× | 1.58× | ||
| Q3 25 | 1.63× | 2.77× | ||
| Q2 25 | 1.23× | 1.25× | ||
| Q1 25 | 0.98× | 0.25× | ||
| Q4 24 | 1.56× | 1.93× | ||
| Q3 24 | 1.52× | 1.56× | ||
| Q2 24 | 1.40× | 1.16× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
